Suppr超能文献

21世纪的骨修复:生物学、化学还是工程学?

Bone repair in the twenty-first century: biology, chemistry or engineering?

作者信息

Hing Karin A

机构信息

Interdisciplinary Research Centre in Biomedical Materials, Queen Mary, University of London, London E1 4NS, UK.

出版信息

Philos Trans A Math Phys Eng Sci. 2004 Dec 15;362(1825):2821-50. doi: 10.1098/rsta.2004.1466.

Abstract

Increases in reconstructive orthopaedic surgery, such as total hip replacement and spinal fusion, resulting from advances in surgical practice and the ageing population, have lead to a demand for bone graft that far exceeds supply. Consequently, a number of synthetic bone-graft substitutes (BGSs) have been developed with mixed success and surgical acceptance. Skeletal tissue regeneration requires the interaction of three basic elements: cells, growth factors (GFs) and a permissive scaffold. This can be achieved by pre-loading a synthetic scaffold with GFs or pre-expanded cells; however, a 'simpler' approach is to design intrinsic 'osteoinductivity' into your BGS, i.e. the capability to recruit and stimulate the patient's own GFs and stem cells. Through investigation of the mechanisms controlling bone repair in BGSs, linking interactions between the local chemical and physical environment, scientists are currently developing osteoinductive materials that can stimulate bone regeneration through control of the scaffold chemistry and structure. Moreover, this body of research is providing the foundations for future generations of BGSs and bone-repair therapies and may ultimately contribute towards improving the quality of life through maintenance of the skeleton and reversal of disease states, as opposed to the mending of broken bones that we currently practice. Will we be able to grow our own bones in a bioreactor for use as autologous graft materials in the future? Could surgery be limited to accidental trauma cases, with greater restoration of function through biochemical or gene therapies? The technology and research probes necessary to this task are currently being developed with the advent of nanotechnology, genomics and proteomics: are we about to embark on a chemical revolution in medicine? This paper aims to discuss some of the current thinking on the mechanisms behind bioactivity and biocompatibility in bone and how a fuller understanding of the interactions between cells and the materials used today could bring about completely new approaches for the treatment of bone fracture and disease tomorrow.

摘要

由于外科手术技术的进步以及人口老龄化,诸如全髋关节置换和脊柱融合等重建整形外科手术的增加,导致对骨移植的需求远远超过了供应。因此,已经开发了多种合成骨移植替代物(BGS),但效果参差不齐,在手术中的接受程度也有所不同。骨骼组织再生需要三种基本要素相互作用:细胞、生长因子(GFs)和适宜的支架。这可以通过在合成支架中预加载GFs或预扩增细胞来实现;然而,一种“更简单”的方法是在BGS中设计内在的“骨诱导性”,即招募和刺激患者自身GFs和干细胞的能力。通过研究控制BGS中骨修复的机制,将局部化学和物理环境之间的相互作用联系起来,科学家们目前正在开发能够通过控制支架化学性质和结构来刺激骨再生的骨诱导材料。此外,这一系列研究正在为下一代BGS和骨修复疗法奠定基础,最终可能有助于通过维持骨骼和逆转疾病状态来提高生活质量,而不是像我们目前所做的那样仅仅修复骨折。未来我们是否能够在生物反应器中培育自己的骨骼用作自体移植材料?手术是否会仅限于意外创伤病例,通过生化或基因疗法实现更大程度的功能恢复?随着纳米技术、基因组学和蛋白质组学的出现,完成这项任务所需的技术和研究手段目前正在开发中:我们即将开启医学领域的化学革命吗?本文旨在讨论当前关于骨骼生物活性和生物相容性背后机制的一些观点,以及更全面地理解细胞与当今所用材料之间的相互作用如何能够为明天的骨折治疗和疾病治疗带来全新的方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验